Hospital Medicine Unplugged

In this episode of Hospital Medicine Unplugged, we dive into Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)—diagnose it early, treat fluid imbalances, and carefully manage hyponatremia.We start with the essentials: identify and treat reversible causes first. Whether it’s medications, malignancy, or pulmonary/CNS disorders, addressing the underlying issue is key. For life-threatening symptoms like seizures or coma, 3% sodium chloride is recommended to quickly reverse cerebral edema, followed by specialist consultation.For nonemergent cases, fluid restriction remains the first-line therapy—typically 1–1.5 liters/day. However, randomized trials show modest benefits. If that doesn't work, consider oral urea (15 g twice daily) for safe, effective treatment. Salt tablets + furosemide can also be used, but they have modest benefits and come with a higher risk of acute kidney injury and hypokalemia, so use cautiously in patients with comorbidities.Next, we cover long-term management with Tolvaptan—a vasopressin receptor antagonist that’s highly effective but comes with monitoring challenges. Cost and monitoring requirements are limiting factors, so use it for refractory cases when other options fail.Emerging therapies are on the horizon: SGLT2 inhibitors (e.g., empagliflozin) show promise, but the data are still limited.Throughout all treatments, close monitoring of serum sodium is essential to avoid rapid correction and dangerous neurologic complications.We wrap up with key pearls for monitoring during therapy:For severe hyponatremia (e.g., <120 mmol/L), monitor serum sodium every 6-8 hours.Tolvaptan and oral urea require daily sodium checks until stable, then less frequently.Always monitor for overcorrection to avoid osmotic demyelination—never correct more than 10 mmol/L in 24 hours.Hospital-specific pearls:• Address reversible causes immediately (discontinue offending medications, treat underlying malignancy or CNS issues).• Fluid restriction is your starting point, but keep the fluid volume under 1.5 L/day.• If oral urea or salt + furosemide don’t work, move to Tolvaptan.• Close sodium monitoring is critical—check every 6–8 hours during active correction.• For severe cases, use 3% sodium chloride but stick to correction limits to avoid neurologic complications.In summary: identify the cause, titrate fluid intake, and monitor sodium levels carefully—SIADH treatment requires precision and diligence to avoid long-term complications like cognitive impairment and fractures.System moves: A SIADH management bundle that:Auto-calculates fluid restriction in the EHR based on patient labs.Orders 3% saline for symptomatic cases.Flags Tolvaptan for refractory cases with specialist input.Sets sodium monitoring schedules for ongoing management.Triggers automatic alerts for SGLT2 inhibitors when appropriate, based on evolving evidence.Managing SIADH requires careful attention to fluid balance, serum sodium, and patient-specific needs—get it right and you’ll prevent neurological complications while improving long-term outcomes.

In this episode of Hospital Medicine Unplugged, we tackle sickle cell disease (SCD)—manage pain, prevent complications, and optimize long-term care.We start with the essentials: rapid pain management and early intervention. For vaso-occlusive crisis (VOC), opioids should be administered within 1 hour of presentation, with individualized dosing based on previous effective regimens. Monitor closely and adjust as needed to achieve adequate analgesia. Adjuncts like NSAIDs can be used when appropriate, and for opioid-refractory pain, consider ketamine infusions or regional anesthesia—but only in select cases, with specialist input.Next, we talk fluids—balanced is the new standard. Lactated Ringer’s may reduce the risk of metabolic acidosis and microvascular sickling compared to normal saline, but practice patterns still favor saline. Keep fluids balanced, and watch for overload, especially in patients with renal or cardiac issues.Complications? Keep a close eye on acute chest syndrome, infection, and stroke—critical threats in the hospital setting. Early recognition is key: treat infection with broad-spectrum antibiotics, perform incentive spirometry to reduce acute chest syndrome risk, and always screen for stroke, especially in patients with abnormal transcranial Doppler velocities.For transfusion therapy, be strategic. Red blood cell transfusions are reserved for severe cases, such as acute chest syndrome or stroke, while simple transfusions are used to manage anemia. Exchange transfusion is the go-to for stroke or severe ACS, aiming to lower sickle hemoglobin and reduce viscosity.We cover long-term management: hydroxyurea is the first-line therapy for preventing VOC and acute chest syndrome, and should be considered for all eligible patients. Crizanlizumab and L-glutamine are options for those who don’t respond well to hydroxyurea. Consider stem cell transplant in eligible patients for curative treatment, especially in children with matched sibling donors.Before discharge, plan for secondary prevention. Ensure patients are on disease-modifying therapies, have received proper vaccinations, and are educated on avoiding triggers like dehydration and infection. Schedule follow-up appointments and reinforce adherence to medications.Hospital-specific pearls:• Use admission to manage pain quickly and initiate fluid therapy—monitor for complications like ACS, infection, and stroke.• Ensure medication reconciliation, particularly with opioids and hydroxyurea—adjust regimens as needed.• Early involvement of nutrition and physiotherapy can help reduce the risk of long-term complications like avascular necrosis and pulmonary hypertension.• Offer alcohol counseling and support for substance use, which can worsen SCD outcomes.We close with system moves: a bundle that (1) auto-calculates FIB-4 for VOC risk in the EHR, (2) triggers early pain management pathways, (3) sends fluid and transfusion orders based on clinical risk, (4) links to specialist consultations for complex cases like stroke, and (5) sets up post-discharge follow-up reminders to optimize care.Pain control saves the day in SCD; preventing complications reduces morbidity; and long-term therapies keep patients out of the hospital—SCD care that’s actionable on the wards and sustainable after discharge.

In this episode of Hospital Medicine Unplugged, we tackle NAFLD—screen smart, stage fibrosis fast, and treat the heart to save the liver.We open with the do-firsts: targeted case-finding, not blanket screening. Prioritize patients with obesity, T2D, metabolic syndrome. Start with FIB-4 (age/AST/ALT/platelets): <1.3 (or <2.0 if >65) = low risk; 1.3–2.67 = indeterminate; >2.67 = high risk. For indeterminate/high, add elastography (VCTE/MRE). Reserve biopsy for discordant NITs or when confirming NASH/advanced fibrosis will change management. Flag that acute illness skews labs—repeat FIB-4 after discharge if values were “hot.”Lifestyle is the therapy with the biggest effect size:• Weight loss targets: ≥5% improves steatosis; ≥7–10% improves NASH/fibrosis.• How: Mediterranean-style diet, energy deficit, and structured exercise (150–300 min/wk moderate or 75–150 vigorous; practical: 2–3 aerobic sessions/wk at ~65–75% max HR).• Even without large weight loss, more activity drops ALT and liver fat.• Alcohol: restrict—even moderate intake can worsen injury.Med & procedure lane (select patients):• Pioglitazone 30–45 mg daily for biopsy-proven NASH (esp. with T2D)—counsel on weight gain/edema/fracture risk.• Vitamin E 800 IU daily only in non-diabetic adults with biopsy-proven NASH—discuss risks.• No broadly approved “NASH drugs” yet; many agents in trials.• Bariatric surgery (right candidates): large, durable weight loss with frequent NASH resolution and fibrosis regression.Treat what actually kills: the cardiometabolic bundle.• T2D: optimize; GLP-1 RA / SGLT2i favored for weight/CV/renal benefits (NAFLD-friendly, even if not NASH-approved).• Lipids: statins are safe across NAFLD (including compensated cirrhosis)—use them.• BP & OSA: control aggressively; screen for sleep apnea.Monitoring & follow-up:• Track fibrosis, not just ALT. Re-check FIB-4 periodically; repeat elastography as risk evolves.• Once cirrhosis (or advanced fibrosis per local policy): HCC surveillance q6 mo, manage varices per guidelines.• Vaccinate (HAV/HBV), reinforce adequate protein, and set realistic weight-loss trajectories (≈0.5–1 lb/week).Hospital-specific pearls:• Use admission to risk-stratify and place outpatient elastography—don’t overcall staging on transient in-hospital labs.• Med rec: stop hepatotoxins where possible; (re)start statin if indicated; align diabetes regimen toward GLP-1/SGLT2 when appropriate.• Document alcohol use and offer brief intervention + supports.• Loop in nutrition early to avoid sarcopenia, especially if decompensated.We close with the system moves: a NAFLD bundle that (1) auto-calculates FIB-4 in the EHR; (2) orders elastography for FIB-4 ≥1.3 or any T2D with risk factors; (3) triggers hepatology e-consult for FIB-4 >2.67, high stiffness, or discordant NITs; (4) defaults a lifestyle pathway (dietitian + exercise referral + written 7–10% weight-loss plan); (5) nudges cardiometabolic optimization (statin-on unless contraindicated; GLP-1/SGLT2 suggestions for T2D); (6) adds an alcohol counseling tile; (7) sets surveillance reminders if advanced fibrosis/cirrhosis; (8) hands the patient a one-page Mediterranean diet + activity roadmap.Fibrosis sets the prognosis; lifestyle moves the needle; cardiometabolic control saves lives—NAFLD care that’s measurable on the wards and durable after discharge.

In this episode of Hospital Medicine Unplugged, we sprint through ascites—tap early, diurese smarter, and keep kidneys/brains out of trouble while you line up the definitive plan.We open with the do-firsts: confirm the syndrome and name the driver. Diagnostic paracentesis on arrival (don’t wait for the CT): send cell count/diff (SBP if PMN ≥250/µL), albumin + total protein (for SAAG), culture (inoculate blood culture bottles at bedside), ± cytology/ADA/amylase if the story is atypical. Read the fluid: SAAG ≥1.1 g/dL → portal HTN (usually cirrhosis); SAAG <1.1 → non-portal (malignancy, TB, pancreas). Protein >2.5 g/dL points to cardiac. Baseline labs: CMP/Cr, INR, CBC, urine Na/K (spot), and ultrasound with Doppler.General moves that matter: Sodium ~<2 g/day (avoid over-restriction—protect nutrition), daily weights/strict I&O, and stop nephrotoxins (NSAIDs, ACEi/ARB, aminoglycosides; pause diuretics if AKI). Multidisciplinary from the jump (hepatology, nutrition, pharmacy).Diuretics—start right, titrate tight: for grade 2 (moderate) ascites, start combo spironolactone 100 mg + furosemide 40 mg daily (1:0.4 ratio), then up-titrate in lockstep. Aim for –0.5 to –1.0 kg/day (slower if no edema). Track K⁺/Cr closely; back off if creatinine rises or Na slides.Paracentesis & albumin: for tense (grade 3) ascites, go straight to large-volume paracentesis for fast relief. If >5 L removed, give albumin 6–8 g per liter to prevent circulatory dysfunction. Long-term albumin between taps? Mixed data—use selectively, not by default.Refractory ascites playbook: when max diuretics + sodium restriction fail, it’s repeat LVP and consider TIPS. TIPS helps control ascites but ups HE risk—avoid with advanced HE, bad cardiac disease, or high MELD; decide with a multidisciplinary huddle. Not a TIPS/transplant candidate? Discuss tunneled peritoneal drains or automated low-flow pumps—quality-of-life gains vs infection/device issues.Complications you can’t miss:• SBP: suspect with any decompensation. Diagnose with PMN ≥250/µL; treat ceftriaxone/cefotaxime (broaden if nosocomial/MDR risk) + albumin 1.5 g/kg day 1, 1 g/kg day 3. Start prophylaxis afterward when indicated.• Hyponatremia: optimize volume/diuretics; fluid restrict only if severe (Na <125) or symptomatic; correct slowly; consider albumin support in select cases.• HRS-AKI: albumin challenge, fix precipitants, then vasoconstrictor + albumin (e.g., terlipressin where available) and fast-track transplant.Special situations & follow-through: reinforce alcohol cessation/viral therapy linkage where relevant, vaccinate (HAV/HBV), nutrition re-build (adequate protein!), and early transplant referral for anyone with refractory ascites or first SBP/renal hit.We close with the system moves: an ascites bundle that (1) auto-fires an admission paracentesis order set (cell count, culture in blood bottles, albumin/protein for SAAG); (2) defaults to combo diuretics with daily weight/I&O targets and lab timers; (3) embeds LVP + albumin dosing when >5 L; (4) pops an SBP pathway (empiric ceftriaxone/cefotaxime + albumin; prophylaxis on discharge if indicated); (5) flags AKI/HRS with a vasoconstrictor + albumin protocol; (6) hard-stops nephrotoxins and cues nutrition consult; (7) triggers TIPS/transplant e-consults for refractory disease; (8) offers palliative options (tunneled drain education, home drainage) when goals-of-care point that way.Tight, tap-first, and transplant-minded—everything your team needs to relieve pressure today and change the trajectory tomorrow.

In this episode of Hospital Medicine Unplugged, we sprint through pleural effusions—scan smart, tap safer, and match treatment to mechanism so your patients breathe easier with fewer procedures.We open with the do-firsts: confirm the effusion and triage the “why.” Go POCUS-first (size, septations, safe pocket), use CXR for laterality, save CT for complexity. Tap if it’s new, unexplained, unilateral, febrile/suspected infection or cancer, or large/symptomatic. Send a full panel: protein, LDH, pH, glucose, cell count/diff, Gram/culture, cytology; add ADA/TB PCR when TB’s on the table. Call it with Light’s criteria; if diuretics muddy the waters, use serum–pleural albumin gradient >1.2 g/dL or NT-proBNP when HF is likely.Drainage decisions—match the mechanism:• Transudates: Treat the cause.– Heart failure: GDMT (diuretics, ARNI, β-blocker, MRA, SGLT2i); tap for dyspnea if needed.– Cirrhosis (hepatic hydrothorax): Na restriction + diuretics; avoid nonselective β-blockers; refractory → serial taps or IPC (avoid in transplant candidates); consider TIPS as bridge to transplant.– Nephrotic/renal: Volume control; repeat taps if symptomatic.• Exudates: Treat the pleura/lung.– Parapneumonic/empyema: Antibiotics early. Drain if pH <7.2, low glucose, high LDH, pus/positive Gram, or loculations. Use small-bore US-guided tube; add tPA + DNase for loculations; escalate to VATS if failing.– TB effusion: Expect paucibacillary fluid; support with NAATs; treat per standard regimen.– Malignant pleural effusion (MPE): Start with a large-volume tap to confirm symptom benefit and test re-expansion. Choose talc pleurodesis (inpatient) or IPC (ambulatory). Nonexpandable (trapped) lung → IPC; pleurodesis won’t take.Procedure pearls (make it boring-safe): US guidance for every tap; remove up to ~1.5 L per session or stop for cough/chest tightness; no routine post-tap CXR unless symptoms/air aspirated. Watch for pneumothorax, bleeding, infection, and re-expansion pulmonary edema.ICU plays: in vented, hypoxemic patients, drain when PaO₂/FiO₂ <200 and estimated effusion >~500 mL—oxygenation usually improves; pneumothorax risk is low but real.Complications you don’t want to miss: loculated collections needing fibrinolytics/surgery, trapped lung (think IPC, not pleurodesis), procedure-related air/bleeding/infection, and recurrent effusions that tank QoL.We close with the system moves: a pleural-effusion bundle that (1) makes POCUS the default for diagnosis and marking; (2) fires a “new/unilateral/unexplained” tap trigger with the full lab set + cytology; (3) auto-adds albumin gradient/NT-proBNP when diuretics or HF suspected; (4) runs a parapneumonic pathway (abx → drain → tPA/DNase → VATS); (5) runs an MPE pathway (test re-expansion → pleurodesis or IPC; IPC for trapped lung); (6) builds a cirrhosis track (Na restriction, diuretics, no NSBB, early TIPS/transplant consult); (7) mandates US-guided procedures and post-tap safety checks; (8) standardizes IPC care/education and follow-up.Fast, ultrasound-led, and decision-forward—everything your team needs to tap smart, treat smarter, and keep patients off the yo-yo of repeat admissions.

In this episode of Hospital Medicine Unplugged, we sprint through rhabdo—spot it early (even without the classic triad), flood fast, and keep kidneys out of trouble.We open with the do-firsts: confirm the syndrome and size the risk. Order CK (diagnostic at >5× ULN; think >5,000 IU/L non-exertional, >10,000 IU/L exertional), BMP (K⁺/Cr), Ca/Mg/Phos, AST/ALT, LDH, UA ± myoglobin, ECG, and urine output with a Foley. Calculate a McMahon score to estimate AKI risk. Hunt the culprit now—trauma/immobility, heat/exertion, alcohol/illicit drugs, statins/antipsychotics/SSRIs/colchicine, infections (including COVID-19), metabolic/endocrine hits, seizures. Limb checks for compartment syndrome.Fluids win or lose the case: start immediately (ideally <6 h from injury). Use isotonic crystalloids (normal saline or balanced solutions—no proven winner); titrate to urine output ≥300 mL/h for the first 24 h while watching for overload. Place on telemetry if K⁺ is climbing. After 24–48 h, taper to avoid pulmonary edema.Electrolytes—treat what kills, ignore what heals:• Hyperkalemia → standard rapid sequence (IV calcium, insulin/dextrose, β-agonist; add bicarbonate if acidotic).• Hypocalcemia → usually do not replace unless symptomatic (tetany, seizures, arrhythmia).• Manage hyperphosphatemia and hypomagnesemia when significant; re-check labs frequently early on.Adjuncts (use sparingly): routine bicarbonate, mannitol, or loops aren’t supported. Consider bicarbonate only for systemic acidosis; consider mannitol if UOP stays <300 mL/h despite fluids. Avoid nephrotoxins (NSAIDs, contrast if you can). Dialysis is for the usual indications (refractory K⁺/acidosis/volume/uremia)—not for CK alone. Extreme myoglobinemia (>10,000 ng/mL) → nephrology for possible hemoadsorption adjunct with RRT.Complications you don’t want to miss: AKI, malignant hyperkalemia, compartment syndrome (surgical fasciotomy), and DIC. Trend CK q6–12 h to peak, electrolytes/Cr q6–8 h early, strict I/Os, and serial limb exams.Special situations & follow-through: stop the offending drug (hold statins; consider future rechallenge only after recovery and risk review), treat triggers (e.g., NMS/serotonin syndrome protocols, infections), and consider genetic workup for recurrent/unexplained cases. Discharge with hydration guidance, trigger avoidance, and a plan to recheck CK/renal function.We close with the system moves: a rhabdo bundle that (1) fires a “CK >5× ULN” order set with Foley + UOP goal; (2) defaults crystalloids with a UOP ≥300 mL/h target and labs q6–8 h; (3) embeds a hyperK pathway; (4) suppresses automatic bicarb/mannitol; (5) auto-pages surgery for compartment red flags and nephrology for high McMahon score/early AKI; (6) hard-stops nephrotoxins; (7) cues med rec for statins/antipsychotics/illicits and a brief return-to-activity plan.Fast, physiology-first, and bedside-ready—everything your team needs to flood early, fix the electrolytes, and save the kidneys.

In this episode of Hospital Medicine Unplugged, we cut through pressure injuries—who to flag on day 1, which beds and dressings actually help, and how to run a wound plan that heals instead of lingers.We open with the do-firsts: risk-stratify (Braden + clinical judgment), full head-to-toe skin check with stage + size + photo, float the heels now, reposition q2h (individualize if unstable), and put silicone prophylactic dressings on sacrum/heels in high-risk patients. Build a moisture plan (barrier creams, manage incontinence, minimize device pressure), order nutrition consult, and page wound care early for Stage 3–4 or anything you’re unsure about.Support surfaces—what to order (and why):• Air-fluidized bed for treatment of advanced/nonhealing ulcers—best evidence for reducing ulcer size vs standard beds.• Advanced static mattresses/overlays for prevention; alternating-air/low–air-loss haven’t shown clear added benefit over standard in most scenarios.• Keep off-loading non-negotiable: heel suspension, chair cushions, limit shear.Local wound care that works:• Moist wound healing is the rule—match dressing to exudate.• Hydrocolloid > gauze for wound-size reduction; hydrocolloid ≈ foam for complete healing. Skip dextranomer paste (inferior outcomes).• Cleanse with saline or non-cytotoxic solutions (no full-strength peroxide/iodine).• Debride devitalized tissue (surgical, enzymatic, or autolytic—no clear winner); reassess weekly with measurements and photos.Nutrition—treat the deficit, not the lab: prioritize protein/AA supplementation when malnourished or intake is inadequate; routine supplements in well-nourished patients haven’t shown consistent benefit. Monitor weight, intake, and inflammatory burden; involve dietetics early.Adjuncts—separate signal from noise:• Electrical stimulation can speed healing but doesn’t reliably increase complete healing; skin irritation can bite frail elders—use selectively.• Electromagnetic therapy, ultrasound, laser: no meaningful benefit vs controls.• Negative-pressure wound therapy: mixed/limited benefit—consider case-by-case (deep, exudative wounds, protecting grafts), not reflexively.Infection & osteo—don’t overtreat colonization:• Treat cellulitis or sepsis clinically; avoid routine surface swab “cultures.”• Suspect osteomyelitis in chronic Stage 4/visible bone—confirm with imaging + bone biopsy when feasible; tailor antibiotics to culture and source control.Surgery—when the wound won’t win conservatively:• Consider flap coverage for advanced/nonhealing ulcers after optimization (off-loading, nutrition, infection control). No technique clearly superior.• Biggest complication: dehiscence (higher with bone removal, ischial sites). Post-op success lives or dies on continued off-loading and surveillance.What not to do:• Gauze-as-default, cytotoxic cleansers, “set-and-forget” dressings, or skipping nutrition.• Ordering fancy beds without daily off-loading and repositioning.• Treating every malodor with antibiotics.We close with the system moves: a pressure-injury bundle that (1) auto-flags high-risk admits and drops a silicone sacral/heel order; (2) defaults to advanced static surface for prevention and air-fluidized criteria for advanced wounds; (3) embeds a staging/size/photo smart form with weekly prompts; (4) hardwires reposition q2h + heel float into nursing orders; (5) triggers nutrition + wound RN consults for Stage ≥2 or any malnutrition; (6) tracks device-related pressure points (oxygen tubing, masks, cervical collars); (7) dashboards prevalence/incidence so we can see if the bundle actually moves rates.Practical, guideline-driven, and bedside-ready—everything your team needs to prevent, treat, and actually heal pressure injuries in the hospital.

In this episode of Hospital Medicine Unplugged, we cut through goals-of-care (GOC) conversations—who to flag, what to say, how to document it so the whole team actually uses it.We open with the do-firsts: identify the right patients (surprise question “Would I be surprised…?”, acute deterioration, high-risk admits, ≥2 recent hospitalizations). Prep before you walk in: scan prior ACP notes/POLST/advance directives, locate the surrogate, check capacity, order an interpreter if needed, and secure a quiet space (+ tissues, sitter coverage). Set the agenda up front: “I want to understand what matters to you and make a plan that fits.”The conversation flow (simple, repeatable):• Ask–Tell–Ask: start with “What’s your understanding of what’s going on?” → share a concise medical summary and prognosis → check understanding.• Elicit values/goals/fears: “What are you hoping for?” “What worries you most?” “What abilities are essential to your quality of life?”• Explore trade-offs: function vs longevity, home vs ICU, burdens you’d accept for benefits you want.• Make a recommendation (values-based): “Given how important being at home and independent is to you, I recommend….”• Code status in context, not in isolation. Use plain language; avoid menu-listing procedures.• Time-limited trials for uncertainty: set goals, time frame, and exit criteria.• Close with teach-back & next steps: summarize decisions, confirm surrogate, plan to revisit.Communication moves that work (and keep you human):• NURSE your empathy—Name, Understand, Respect, Support, Explore.• Short sentences, zero jargon, one idea at a time; pause for emotion.• Calibrate detail to health literacy; invite family, but center the patient.• When capacity is impaired: confirm surrogate hierarchy, reflect known values; involve ethics early if conflict.Special scenarios—how we handle them fast:• ICU or rapid decline: early palliative consult; consider a time-limited trial of ICU-level care with defined milestones.• Conflict or ambivalence: normalize, re-align to stated values, schedule a second touch with key stakeholders present.• Language & culture: professional interpreters only; ask about cultural or spiritual needs that influence decisions.• Equity: proactively offer GOC to all eligible patients; don’t wait for “readiness”—our system prompts it.What not to do (aka classic fail points):• Opening with “Full code or DNR?” before exploring values.• Info dumps without check-ins; euphemisms (“do everything”) and statistics without context.• One-and-done conversations—goals evolve; your notes should too.Documentation that drives care (and survives handoffs):• Use the GOC template with discrete fields: capacity, surrogate/contact, values & priorities, prognosis discussed, recommendations, code status, time-limited trials (goals/criteria/timeline), hospice/palliative referrals, revisit date.• Enter aligned orders (code status, limits of treatment, DNI/DIALYSIS preferences) before you leave the floor.• Title your note “Goals of Care” and pin it to the header/inbox so ED/ICU can find it in 10 seconds.We close with the system moves: a GOC bundle that (1) auto-flags candidates via the surprise question + high-risk diagnoses; (2) fires an EHR prompt + conversation guide in the admission navigator; (3) standardizes the GOC note and links it to code-status orders; (4) routes to palliative care for triggers (ICU admit, refractory symptoms, complex conflict); (5) builds training + feedback loops (review a short audio or template at noon conference); (6) dashboards equity metrics so every patient gets the offer.Clear, compassionate, and actionable—everything your team needs to run patient-centered goals-of-care talks that actually change the plan at the bedside.